Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Healthtrust
Julphar
Fuji
Argus Health
Merck
Mallinckrodt
Cantor Fitzgerald
AstraZeneca

Generated: April 26, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074565

« Back to Dashboard

NDA 074565 describes SELEGILINE HYDROCHLORIDE, which is a drug marketed by Apotex, Dava Pharms Inc, Lannett Holdings Inc, Apotex Inc, Boscogen, Chartwell Molecules, G And W Labs Inc, Mylan, Siegfried, and Somerset, and is included in thirteen NDAs. It is available from seven suppliers. Additional details are available on the SELEGILINE HYDROCHLORIDE profile page.

The generic ingredient in SELEGILINE HYDROCHLORIDE is selegiline hydrochloride. There are seventeen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the selegiline hydrochloride profile page.
Summary for 074565
Tradename:SELEGILINE HYDROCHLORIDE
Applicant:Chartwell Molecules
Ingredient:selegiline hydrochloride
Patents:0
Therapeutic Class:Antiparkinson Agents
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength5MG
Approval Date:Aug 2, 1996TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Moodys
Mallinckrodt
US Army
Covington
US Department of Justice
Merck
Medtronic
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.